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The effect of brain aging and Rb1 on the learning and memory of
C57BL/6J mice was tested by different behavioral tests including Y
maze and Morris. The aged neuron was examined by the enzyme
staining and electron microscope scanning, oxidative stress in brain
tissue was tested by ELISA or spectrophotometer, and the plasticity-
related proteins and the mTOR signaling pathway in hippocampus
were tested by immunohistochemistry staining and Western blot.
RESULTS
1. Long-term low dose oral supplementation of Rb1 increased the
average and maximum lifespan and improve aged-related cognitive
decline.
2. Rb1 reduce the levels of MDA, protein carbonylation and improve
SOD activity on brain tissue.
3. In the brain tissues of old controls, Rb1 reverse the over expression of
mTOR/p70S6K pathway activation, then improve the cognitive
function.
CONCLUSIONS Rb1 could prolong the lifespan and protect mice brain
via restraining mTOR pathway activation. Consequently, Rb1 may be a
effective and safe effective health medicine for anti-aging.
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OBJECTIVES To observe whether CD137 promotes angiogenesis by
modulating endothelial CD137/NFATc1 signaling.
METHODS Agonist-CD137 antibody and anti-CD137 antibody were
used to activate or block CD137 axis respectively in ApoE-/- mice or
HUVEC. The expression of CD137 mRNA and NFATc1 mRNA were
measured by real-time quantitative PCR (RT-qPCR). The levels of
phospo-Smad1/5 (Ser463/465), phospo-Smad2(Ser465/467) and
NFATc1 of the HUVECs were determined by Western blot. Eukaryotic
expression vector were constructed and co-transfected to the 293T
with mimics or inhibitors to measure the protein level. Stable HUVEC
cell line which knock-down NFATc1 or overexpress NFATc1 and con-
trol were built by lenti-virus. CCK-8 assay and transwell assay were
performed to detect the proliferation and migration of cell. the
Matrigel human umbilical vein endothelial cell (HUVEC) tube-forma-
tion assay and aortic rings assay were did to investigate whether LRG1
promotes blood vessel growth. Agonist CD137 antibody were used in
ApoE-/- mice and Immunohistochemistry or Masson’s trichrome assay
were performed to observe the plaque stability.
RESULTS phospo-Smad2(Ser465/467) expression was downregulate
(0.400.08 VS 1.000.00, p <0.05), whereas expression of nuclear
factor of activated T-cells c1 (NFATc1) and phospo-Smad1/5 (Ser463/
465) were signiﬁcantly up-regulated(2.120.21 VS 1.000.00,
2.560.23 VS 1.000.00). Overexpression of NFATc1 by plasmid
transfection demonstrated that NFATc1 independently contributed to
HUVEC tube and branch formation. Inhibition of Smad1 downregulated
NFATc1 in vitro. Knockdown NFATc1 suppressed the proliferation and
migration of HUVEC induced by CD137. Up-regulating NFATc1 through
agomir in Apoe-/- mice signiﬁcantly increased angiogenesis in athero-
sclerotic lesion areas induced by CD137 in multi ways.
CONCLUSIONS Results indicate that CD137/NFATc1 pathway plays an
important role in angiogenesis and Smad1/5 is involved in this pro-
gression cooperates with NFATc1.
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OBJECTIVES Physiological adaptations to microgravity involve al-
terations in cardiovascular, neuromuscular, and neuroendocrine sys-
tems. These adaptations result in cardiac remodeling and orthostatic
hypotension. Recent studies have found that microRNAs emerged as
powerful and important modiﬁers of cardiovascular diseases. How-
ever, the role of microRNAs in weightlessness-induced cardiac
remodeling is unknown. The purpose of this paper was to identify
weightlessness-responsive microRNAs and to explore their role in
weightlessness-induced cardiac remodeling.METHODS In mice, hindlimb unloading (HU) mimics the effects of
microgravity. Three groups mice were subjected to HU by tail sus-
pension for 28 days and two of these three groups recovered 7 and 14
days respectively after HU ( HU, n¼10; R7, n¼9; R14, n¼9 ), the control
group (n ¼ 11) were treated equally, with the exception of tail sus-
pension. Cardiac structure and function were detected in all groups by
echocardiography on 4th, 5th and 6th week after HU respectively, and
the microRNAs levels of serum and heart were detected by Q-PCR.
RESULTS Echocardiography revealed cardiac enlargement and
decreased contractility in HU group. Compared with control, the HU
group mice showed higher HW/BW (ratio of heart weight to body
weight), LVIDs (systolic left ventricular internal diameter) and LV Vols
(systolic left ventricular volume), lower LV EF (left ventricular ejection
fraction) and LVFS (left ventricular fractional shortening). However,
mice recovered 7 days after HU (R7) showed much higher HW/BW,
LVIDs and LV Vols than both control and HU group. Mice recovered 14
days after HU (R14) returned to the normal state. Meantime, the results
of Q-PCR demonstrated that miR-199a-3p of serum was upregulated in
HU group, continued to be increased in R7 group, and returned to
normal state in R14 group. More interestingly, variation trends of miR-
199a-3p in left ventricle were consistent with the serum.
CONCLUSIONS These results indicate that simulated microgravity
lead to cardiac remodeling, and the remodeling could be recovered,
but in the early stage of recovering, cardiac remodeling may be more
intensiﬁed because of increased pressure load. Meanwhile, miR-199a-
3p is likely to play an important role in cardiac remodeling induced by
simulated microgravity, miR-199a-3p may act as a biomarker of
simulated microgravity induced cardiac remodeling.
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OBJECTIVES Hyperactivity of the cardiac sympathetic nerve system
may underlie the pathogenesis of inappropriate sinus tachycardia
(IST) and stellate ganglion (SG) block has been reported therapeutic
for medically refractory IST. Investigations have proved that cervical
vagal stimulation could inhibit SG activity.
METHODS Sixteen anesthetized dogs were randomly divided into the
noninvasive vagal nerve stimulation (NVNS) group (n¼8) and the
control group (n¼8) to receive 3 hours of right side noninvasive vagal
nerve stimulation (at the voltage 80% below the threshold that
deﬁned as the minimal voltage to slow the sinus rate or atrioven-
tricular conduction) or sham stimulation. The maximal sinus rate
acceleration induced by high frequency stimulation (HFS) of right
stellate ganglion (RSG) and RSG neural activity were measured at
baseline and the end of each hour of stimulation. SK2, c-fos and NGF
protein expression in RSG were examined in both groups.
RESULTS After 3 hours of stimulation, the maximal sinus node ac-
celeration induced by HFS of RSG and RSG neural activity were
signiﬁcantly attenuated in NVNS group compared with those at
baseline(P <0.05), no signiﬁcant changes of these indices were
observed in the control group (P >0.05). SK2 expression in RSG was
signiﬁcantly higher and c-fos and NGF expressions were signiﬁcantly
lower in the NVNS group than in the control group (P <0.05).
CONCLUSIONS Noninvasive vagal nerve stimulation may suppress
RSG activity possibly by modulating SK2, c-fos and NGF expressions in
RSG, thus inhibiting sympathetically induced sinus node acceleration.
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OBJECTIVES Calreticulin (CRT) is major Ca2þ -binding protein
mainly resident in the endoplasmic reticulum (ER) lumen. Evidences
